Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of intravenous RPX2003 (biapenem) in healthy adult subjects; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• RPX2003 (biapenem)

Snippet

Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | Conditions: Healthy Volunteers, Bacterial Infections | Phase 1 | Status: COMPLETED